×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now
Pfizer to invest $470m to expand research into mRNA vaccines

The US pharma giant will construct a new building and renovate existing facilities at its Pearl River campus in the US

Adcock Ingram misses out on main ARV tender despite state’s localisation goal

SA pharmaceutical manufacturer overlooked as department of health awards half of R11bn antiretroviral tender to companies in India

Ascendis jumps as it inks R410m deal to sell pharma unit

Sale to lenders is necessary to avoid ratcheting up debt payments, and the figure is R35m higher than a competing offer

Adcock Ingram’s share price shoots up on profit news

The pharmaceutical manufacturer said in a trading statement it expects headline earnings per share to increase by at least 20% year on year

Former Theranos president Sunny Balwani convicted of fraud

Balwani was found guilty of all charges against him for his role in the collapse of the $9bn blood-testing start-up

Mediclinic surges as Remgro proposes healthier offer

Remgro and consortium partner MSC have increased their offer to 504p per share for SA’s most valuable hospital group

Netcare chair Thevendrie Brewer resigns

Brewer joined the board in January 2011 as an independent nonexecutive director, was appointed deputy chair in November 2015 and promoted to chair in April 2018

Aspen hopeful about future vaccine orders

The pharmaceutical giant is optimistic international procurement agencies will heed clarion calls to procure African-produced vaccines

Mediclinic shares jump as market anticipates fatter takeover offer

Equity traders bet the Remgro-led consortium is likely to return with a higher bid

AstraZeneca-Daiichi drug shown to cut death rate of women with advanced breast cancer

Enhertu extends survival rate of patients compared to standard chemotherapy, data shows

Mediclinic jumps as divisions show Covid-19 recovery

The group’s shares had their best day in seven months on Wednesday after it said all of its divisions were bringing in more revenue than before the pandemic

Netcare warns about drags on future performance

Consumers will be under pressure and there may be a cost of living crisis, hospital operator says

What will become of SA’s vaccine makers after Aspen’s failure?

The outcome is a blow for African governments that had hoped to see newly established facilities used for more than just Covid-19

Ascendis secures yet another set of lenders and gets more time

The group has another new set of financiers, which has given it an extra five months, as well as better terms, to repay the debt

Ascendis Health talks to possible new lenders

Dissenting shareholders had been elected to the Ascendis’s board last week, raising the prospect of its current lenders calling in their debt

Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.